Publication: 191

Publication: 191

ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Blood vol 118 (26) 6920-6929

Year:: 2011
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 1

Parents:: 467
Children:: None

Program:: TRP
Primary Committee:: Leuk Corr Sci
Sec. Committees:

Pharmas:
Grants:: CA33601, P50 CA140158, CA140158, CA16058, CA101140, U10 CA077658, CA41287, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, U10 CA041287, P30 CA016058, CA77658, CA129657, CA114725, CA31946

Corr. Author:
Authors:: Klaus H. Metzeler Heiko Becker Kati Maharry Michael D. Radmacher Jessica Kohlschmidt Krzysztof Mrózek Deedra Nicolet Susan P. Whitman Yue-Zhong Wu Sebastian Schwind Bayard L. Powell Thomas H. Carter Meir Wetzler Joseph O. Moore Jonathan E. Kolitz Maria R. Baer Andrew J. Carroll Richard A. Larson Michael A. Caligiuri Guido Marcucci Clara D. Bloomfield

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-20202, CALGB-8461, CALGB-9665
Phases:: N/A

Keywords:: Clinical Trials and Observations, Myeloid Neoplasia